title: Risks of self-injection therapy for impotence.
authors.forename: R J
authors.initials: RJ
authors.lastname: Millard
authors.forename: P D
authors.initials: PD
authors.lastname: Stricker
authors.forename: W J
authors.initials: WJ
authors.lastname: Lynch
authors.forename: T E
authors.initials: TE
authors.lastname: Dean
authors.forename: G F
authors.initials: GF
authors.lastname: Murnaghan
authors.forename: F H
authors.initials: FH
authors.lastname: Breslin
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects*; D010410:Penile Erection / Q000187:drug effects; D010646:Phentolamine / Q000008:administration & dosage / Q000009:adverse effects*; D011317:Priapism / Q000139:chemically induced*; D012646:Self Administration
chemical_list: D010208:Papaverine; D010646:Phentolamine